to study search History No further version available for comparison

Emotion Recognition and Social Cognition in JME patients

Organizational Data

DRKS-ID:
DRKS00011216
Recruitment Status:
Recruiting planned
Date of registration in DRKS:
2016-10-21
Last update in DRKS:
2016-10-21
Registration type:
Prospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

Juvenile myoclonic epilepsy (JME) is a very common form of epilepsy with a high genetic predisposition. This form of epilepsy usually begins in puberty and poor social adjustments as well as behavioral difficulties are often observed in patients with JME. Recent brain imaging studies showed that such emotional and behavioral problems are associated with structural and functional alterations of certain brain areas. However, till now, there are no neuroimaging or neuropsychological studies related to emotion processing in patients with JME with focus on limbic structures. Thus, the aim of this study is so show possible changes in emotion processing and social cognition in patients with JME from multiple aspects by using structural and functional imaging methods as well as neuropsychological and psychiatric examinations. In order to identify possible differences, the results of JME patients will be compared with the results of healthy controls as well as siblings of patients with JME. Further, newly diagnosed patients will be compared to patients who have a long-standing course of the disease. Results of this study may help to develop new psychological and pharmacological intervention strategies and further lead to a better management of social and behavioral difficulties in patients with JME.

Brief summary in scientific language

Juvenile myoclonic epilepsy (JME) is the most common age-related idiopathic generalized epilepsy with a high genetic predisposition, comprising 5-10% of all epilepsies. JME begins usually in puberty with the peak between 14 and 16 years. Poor social adjustment and behavioral disturbances, which resemble frontal lobe dysfunction, are often observed in JME. Recent studies demonstrate an elevated prevalence of psychiatric disorders in JME patients, particularly anxiety, mood, and mild to moderate cluster B personality disorders. These psychiatric disturbances contribute to incompliance of JME patients with regard to intake of antiepileptic drugs and avoidance of trigger factors of seizures. Incompliance frequently causes persistence of seizures and perpetual psychiatric problems leading to a vicious circle. In recent advanced brain imaging studies on JME patients, emotional and behavioral problems have been associated to subtle structural and functional alterations mainly in frontal cortex and thalamus. Morphological and functional abnormalities may extend beyond thalamo-cortical circuitry and involve cingulate, occipital and insular cortices as well as hippocampi and cerebellum. There is emerging evidence that patients with abnormal emotion processing and regulation, such as those with bipolar disorder, show disrupted connectivity between limbic structures and frontal cortices. There are no neuroimaging or neuropsychological studies related to emotion processing in patients with JME with focus on limbic structures. There is an unmet need of understanding of pathophysiological mechanisms of emotion dysregulation which may predispose to behavioral disturbances and poor social adjustment in JME patients. We aim to address the problem of emotional disturbances and social adjustment in JME patients from multiple aspects through thorough functional and structural assessment which would potentially enable elaboration of an unifying concept explaining neurobiological background of disturbances in emotional processing and social adjustment in JME patients. This will be achieved by (i) employing novel neuropsychological test batteries and fMRI paradigms for assessment of emotion recognition and social cognition; (ii) utilizing novel techniques for macro- and microstructural evaluation of brain structures involved in emotion recognition and social cognition and their connections with other brain areas, particularly with frontal lobes; (iii) by comparing for a first time the results of functional and structural alterations in patients with newly diagnosed versus longstanding JME in order to determine causative relationship of possible functional / structural deficits with ongoing seizure activity; (iv) by comparing functional / structural data of JME patients with similar data of their siblings and healthy controls for ascertaining whether functional / structural alterations could be specific for JME. Results of this study may potentially enable developing of psychological and pharmacological interventional strategies for managing behavioral disturbances in patients with JME.

Health condition or problem studied

ICD10:
G40 - Epilepsy
Free text:
Juvenile myoclonic epilepsy (JME)
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Patients: Patients with juvenile myoclonic epilepsy (JME): Visit 1: psychiatric examination; Visit 2: neuropsychological testing; Visit 3: structural and functional Imaging.
Arm 2:
Controls I: healthy subjects: Visit 1: psychiatric examination; Visit 2: neuropsychological testing; Visit 3: structural and functional Imaging.
Arm 3:
Controls II: siblings of patients with JME: Visit 1: psychiatric examination; Visit 2: neuropsychological testing; Visit 3: structural and functional Imaging.

Endpoints

Primary outcome:
The main goal of this study is to determine structural and functional substrates of deficits in emotion processing and social cognition in patients with JME. In order to achieve the main goal we will develop the following strategies: • Psychiatric profile of JME patients as well as healthy controls and siblings of JME patients will be assessed. JME patients will thereafter be divided into two groups: those with and without Axis I and/or II psychiatric disorders according to DSM IV criteria. • Emotion processing and social cognition will be assessed by means of specific neuropsychological tests in patients with JME as well as healthy controls and siblings of JME patients. Those tests compose various tests to examine (i) emotion recognition (Facial Expressions of Emotion: Stimuli and Tests (FEEST), Empathy Quotient (EQ)), (ii) Theory of Mind (ToM) tests (Reading the Mind in the Eyes Test, Moving Triangles, Faux Pas Test), (iii) tests to examine executive functions (Wechsler Intelligence Scale for Adults and Children, Wisconsin Card Sorting Test (WCTS), Trail Making Test A & B (TMT A & B), Regensburger Wortflüssigkeitstest (RWT), Toronto-Alexithymia Scale (TAS-26)) as well as (iv) a self-report questionnaire to examine depression and anxiety symptoms (Hospital Anxiety and Depression Scale (HADS-D)). • Morphological and functional imaging assessment (magnetic resonance imaging (MRI) and functional magnetic resonance imaging (fMRI)) of limbic structures in two groups of JME patients (with and without Axis I and/or II psychiatric disorders) as well as healthy controls andsiblings of JME patients will be performed. • Imaging and neuropsychological data in two groups of JME patients (with and without Axis I and/or II psychiatric disorders) as well as with the similar data of healthy controls and siblings of JME patients will be compared. • Imaging and neuropsychological data of two groups of JME patients: those with newly manifested JME (maximum disease duration 3 years) and those with longstanding JME (disease duration over 3 years) as well as with the similar data of healthy controls and siblings of JME patients will be compared.
Secondary outcome:
No Entry

Study Design

Purpose:
Other
Retrospective/prospective:
No Entry
Study type:
Non-interventional
Longitudinal/cross-sectional:
No Entry
Study type non-interventional:
No Entry

Recruitment

Recruitment Status:
Recruiting planned
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Austria
Number of study centers:
Multicenter study
Recruitment location(s):
  • University medical center Abteilung für Neurologie Salzburg
  • University medical center Abteilung für Neurologie Innsbruck

Recruitment period and number of participants

Planned study start date:
2016-11-01
Actual study start date:
No Entry
Planned study completion date:
No Entry
Actual Study Completion Date:
No Entry
Target Sample Size:
200
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
14 Years
Maximum Age:
no maximum age
Additional Inclusion Criteria:
Inclusion criteria for patients: - Electro-clinical diagnosis of JME based on Classification of the International League against Epilepsy - Patients aged 14 years or older with willingness to participate in the project (informed consent will be obtained from all patients and/or parents of paediatric patients aged between 14 and 18 years) - Patients with ability to participate in MRI and fMRI studies Inclusion criteria for controls (healthy subjects and siblings of patients with JME): - Healthy subjects and siblings of patients with JME aged 18 years or older with willingness to participate in the study

Exclusion Criteria

Exclusion criteria for patients: - Occurrence of epileptic seizure <72 hours prior to MRI &fMRI study - Patients with medical and/ or neurological illnesses other than JME (except for cluster B psychiatric disorders) - Intake of Topiramate and / or Benzodiazepine - Structural lesion on MRI - Incompatibility with MRI investigation - Pregnancy Exclusion criteria controls (healthy subjects and siblings of patients with JME):: - Individuals with medical and/ or neurological illnesses - Individuals with EEG abnormalities (applies to siblings of patients with JME. All of them will undergo routine EEG) - Structural lesion on MRI - Incompatibility with MRI investigation - Pregnancy

Addresses

Primary Sponsor

Address:
Universitätsklinik für Neurologie der Paracelsus medizinischen Privatuniversität Salzburg
Univ.-Prof. Dr. Mag. Eugen Trinka
Ignaz-Harrer-Str. 79
5020 Salzburg
Austria
Telephone:
+43 (0) 5 7255 30200
Fax:
+43 (0) 5 7255 30399
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.salk.at/107.html
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Universitätsklinik für Neurologie der Paracelsus medizinischen Privatuniversität Salzburg
Univ.-Prof. Dr. Mag. Eugen Trinka
Ignaz-Harrer-Str. 79
5020 Salzburg
Austria
Telephone:
+43 (0) 5 7255 30200
Fax:
+43 (0) 5 7255 30399
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.salk.at/107.html

Contact for Public Queries

Address:
Universitätsklinik für Neurologie der Paracelsus medizinischen Privatuniversität Salzburg
Mag. Elisabeth Schmid
Ignaz-Harrer-Str. 79
5020 Salzburg
Austria
Telephone:
+43 (0) 5 7255 56788
Fax:
+43 (0) 5 7255 34899
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.salk.at/107.html

Principal Investigator

Address:
Universitätsklinik für Neurologie der Paracelsus medizinischen Privatuniversität Salzburg
Univ.-Prof. Dr. Mag. Eugen Trinka
Ignaz-Harrer-Str. 79
5020 Salzburg
Austria
Telephone:
+43 (0) 5 7255 30200
Fax:
+43 (0) 5 7255 30399
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.salk.at/107.html

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
Fonds zur Förderung der wissenschaftlichen Forschung (FWF)Haus der Forschung
Sensengasse 1
1090 Wien
Austria
Telephone:
+43-1-505 67 40
Fax:
+43-1-505 67 39
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.fwf.ac.at

Private sponsorship (foundations, study societies, etc.)

Address:
Paracelsus Medizinische Privatuniversität Salzburg
Strubgasse 21
5020 Salzburg
Austria
Telephone:
+43 (0) 662 24200
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
http://http:/www.pmu.ac.at

Ethics Committee

Address Ethics Committee

Address:
Amt der Salzburger Landesregierung Ethikkommission für das Bundesland Salzburg [Amt der Salzburger Landesregierung, Ethikkommission für das Bundesland Salzburg]
Sebastian-Stief-Gasse 2, Postfach 527
5020 Salzburg
Austria
Telephone:
No Entry
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
https://www.salzburg.gv.at/dienststellen/abteilungen/209/20901/415/ethikkommission

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2013-06-06
Ethics committee number:
1638
Vote of the Ethics Committee:
Approved
Date of the vote:
2013-06-26

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry